IP Library Granted Patent US 10,479,753
Granted Patent B2
US 10,479,753 · App. 16/112,761 · Granted Nov 19, 2019

Sacubitril intermediate and preparation method thereof

Inventors: Lei Chen (Dongguan, CN); Guodong Sun (Dongguan, CN); Xiaodong Han (Dongguan, CN); Shun Li (Dongguan, CN); Jiebin Zeng (Dongguan, CN); Zhongqing Wang (Dongguan, CN); Zhonghua Luo (Dongguan, CN)
Assignee: SUNSHINE LAKE PHARMA CO., LTD
C07C59/205C07C45/65C07C49/35C07C51/09C07C67/317C07C69/716C07C231/02C07C231/12C07C233/11C07C233/47C07F7/1892
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,479,753
App. No.
16/112,761
Granted
Nov 19, 2019
Kind
B2
Abstract

The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate disclosed herein can be prepared by a deprotection reaction of a compound. In addition, the intermediate can be used as a raw material to synthesize sacubitril. The method disclosed herein has advantages of easily obtained raw materials, simple preparation process, low cost, environment friendly, and etc., which is very suitable for industrial production.

Claims (63)

1. A method of preparing sacubitril,

comprising the following steps:

a) preparing a compound of Formula (VI) by an enzymic catalytic reaction of a compound of Formula (V) in the presence of ω-transaminase and phosphopyridoxal,

b) optionally, preparing a compound of Formula (VII) from the compound of Formula (VI):

c) preparing sacubitril from the compound of Formula (VII),

wherein:

R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate;

R 2 is

R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; and

R 4 is H, —(C 1 -C 4 )alkyl, —(C 3 -C 6 )heterocyclyl, —(C 1 -C 4 )alkyl-aryl, trimethylsilyl, triethylsilyl or t-butyldimethylsilyl.

2. The method of claim 1 ,

wherein the compound of Formula (V) is prepared by a deprotection reaction of a compound of Formula (IV):

in the presence of a base or an acid, wherein:

R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate;

R 2 is

 and when R 1 is phenyl, R 2 is not

R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl;

R 4 is H, —(C 1 -C 4 )alkyl, —(C 3 -C 6 )heterocyclyl, —(C 1 -C 4 )alkyl-aryl, trimethylsilyl, triethylsilyl or t-butyldimethylsilyl; and

R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl.

3. The method of claim 2 , compound of Formula (IV) is prepared by a substitution reaction of a compound of Formula (II) with a compound of Formula (III) in the presence of a base;

4. The method of claim 3 , compound of Formula (II) is prepared by a condensation reaction of a compound of Formula (I);

wherein R 1 is as defined above; and

R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl.

5. The method according to claim 2 , wherein the compound of the Formula (IV) is prepared by a process comprising the following steps:

a) preparing a compound of Formula (II) by a condensation reaction of a compound of Formula (I) in the presence of a base,

b) preparing a compound of Formula (IV) by a substitution reaction of the compound of Formula (II) with a compound of Formula (III) in the presence of a strong base;

wherein R 1 is phenyl;

R 2 is

R 3 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl or benzyl;

R 4 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, benzyl, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, triphenylmethyl, tetrahydrofuryl;

R 5 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl or benzyl; and

R 6 is triflate, mesylate or 4-methylbenzenesulfonate.

6. The method of claim 5 wherein the compound of Formula (II) is prepared by a condensation reaction of the compound of Formula (I) with N,N′-carbonyldiimidazole and a compound of Formula (VIII):

in the presence of magnesium chloride and triethylamine, wherein R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl.

7. The method of claim 5 , wherein the compound of Formula (II) is prepared by a condensation reaction of the compound of Formula (I) with Meldrum's acid, 4-dimethylaminopyridine, R 5 OH and pivaloyl chloride in the presence of N,N-diisopropylethylamine, R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl.

8. The method of claim 1 , wherein R 1 is phenyl; R 2 is

and R 3 is methyl, ethyl, propyl, i-propyl, n-butyl, t-butyl, benzyl or optionally substituted benzyl.

9. The method of claim 1 , comprising the following steps:

a) preparing a compound of Formula (VII) by an enzymic catalytic reaction of a compound of Formula (V):

in the presence of ω-transaminase and phosphopyridoxal; and

b) preparing sacubitril by an amide condensation reaction of the compound of Formula (VII) with succinic anhydride,

wherein R 1 is phenyl, and R 2 is

and R 3 is ethyl.

10. The method of preparing sacubitril of claim 1 , wherein the compound of Formula (VII) is prepared by a hydrolysis reaction of the compound of Formula (VI) and then an esterification reaction of the hydrolysis product with ethanol.

11. The method of claim 1 , wherein the compound of the Formula (VII) is prepared by a process comprising the following steps:

a) preparing a compound of Formula (X) by a reaction of a compound of Formula (V) with a compound of Formula (IX),

b) preparing a compound of Formula (XI) from the compound of Formula (X),

c) preparing a compound of Formula (XII) from the compound of Formula (XI),

d) preparing a compound of Formula (VII) from the compound of Formula (XII),

wherein:

R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate;

R 2 is

R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; and

R 7 is phenyl, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl.

12. The method of claim 11 , wherein the compound of Formula (IX) in step a) is D-phenylglycinol.

13. The method of claim 11 , wherein the compound of Formula (XI) is prepared from the compound of Formula (X) in the presence of titanium tetrachloride and triethyl silicane in step b).

14. The method of claim 11 , wherein the compound of Formula (XII) is prepared from the compound of Formula (XI) in the presence of palladium-carbon in step c).

15. The method of claim 11 , wherein the compound of Formula (VII) is prepared from the compound of Formula (XII) in ethanol in the presence of an acid in step d).

16. The method of claim 11 , wherein the compound of the Formula (VII) is prepared by a process comprising the following steps:

a) preparing a compound of Formula (XIII) by a reaction of (R)-5-([1,1′-biphenyl]-4-yl)-2-methyl-4-oxopentanoic acid with D-phenylglycinol,

b) preparing a compound of Formula (XIV) from the compound of Formula (XIII) in the presence of titanium tetrachloride and triethyl silicane,

c) preparing a compound of Formula (XII) from the compound of Formula (XIV) in the presence of palladium-carbon,

d) preparing a compound of Formula (VII) by a ring opening reaction of the compound of Formula (XII):

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2020
From: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
To: SUNSHINE LAKE PHARMA CO., LTD.
Reel/Frame 052871/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2019
From: SUNSHINE LAKE PHARMA CO., LTD.
To: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
Reel/Frame 050939/0220 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2018
From: CHEN, LEI; SUN, GUODONG; HAN, XIAODONG; LI, SHUN; ZENG, JIEBIN; WANG, ZHONGQING; LUO, ZHONGHUA
To: SUNSHINE LAKE PHARMA CO., LTD.
Reel/Frame 046956/0225 →
Priority Claims (1)
CN 2016 1 0111396 · Feb 29, 2016 · national
Continuity (2)
Continuation In Part PCTCN2017075097 · Feb 28, 2017
Related Publication 20180362439A1 · Dec 20, 2018